Many genetic neurodevelopmental disorders are diagnosed in childhood—but some patients reach adulthood undiagnosed, particularly if earlier evaluations were limited or never pursued. Nearly 1 in 5 patients with autism, intellectual disability (ID), or developmental delay will have an identifiable underlying genetic cause. Identifying that cause can reshape the treatment plan, flag medical issues that need monitoring, and prompt evaluation of at-risk relatives.

When to Suspect a Genetic Condition

• Autism, ID, or global developmental delay

• Dysmorphic features or congenital anomalies (atypical facial traits, cardiac or renal defects)

• Family history of ID or autism in multiple relatives

• Repetitive or stereotyped behaviors (eg, hand-flapping, rocking)

• New-onset cognitive or functional decline in adolescence or early adulthood

Key Syndromes Psychiatrists Are Most Likely to Encounter

22q11.2 Deletion Syndrome (DiGeorge Syndrome)

• Up to 30% of individuals develop psychosis resembling schizophrenia—one of the strongest known genetic risk factors for psychotic illness

• Clinical clues: treatment-resistant psychosis + history of cleft palate repair, congenital heart disease (especially tetralogy of Fallot), hypocalcemia, or immune deficiency

• Also associated with anxiety and ADHD; found in ~1 in 4,000 live births

Fragile X Syndrome

• Most common inherited cause of intellectual disability; also the most relevant genetic condition to consider in adult males with autism and ID

• Males: moderate-to-severe ID, autism (25%–50%), ADHD, anxiety, stereotypies, long face, prominent ears, macroorchidism, mitral valve prolapse, joint laxity

• Female premutation carriers: anxiety, attention problems, learning difficulties, and risk for fragile X–associated primary ovarian insufficiency

• X-linked inheritance: a maternal uncle and cousin with ID/autism suggests this diagnosis

Prader-Willi Syndrome

• Most often encountered in the context of behavioral crises; mild-to-moderate ID

• Hallmark: hyperphagia (insatiable drive to eat); strict food access management is essential

• Psychiatric features: compulsivity (skin picking, hoarding), severe emotional dysregulation, anxiety, depression, and occasionally psychosis

• The combination of compulsive eating and skin picking should put Prader-Willi on the differential

Understanding and Ordering Genetic Testing

Genetic testing is not a single test—it is a tiered toolkit:

• Chromosomal microarray (CMA): First-tier test; detects most deletions and duplications underlying these syndromes

• Fragile X testing: Must be ordered separately—the trinucleotide repeat expansion does not appear on CMA

• Karyotyping: Useful when a whole-chromosome condition is suspected (eg, Down syndrome, Turner syndrome)

• Comprehensive sequencing: Consider if first-tier testing is negative but suspicion remains high; refer to genetics

For most adults with unexplained ID or autism who have never been tested, start with CMA plus fragile X testing. Coordinate with a genetic counselor for pre- and post-test counseling.

Practical Considerations

• Insurance generally covers CMA and fragile X testing when documented developmental delays, autism, or ID are present; check preauthorization requirements

• Out-of-pocket costs: CMA typically $500–$1,500; fragile X testing ~$300–$500; results in 2–4 weeks

• If testing cannot be completed during hospitalization, initiate an outpatient referral before discharge

• Discuss the possibility of incidental findings (eg, BRCA-related cancer predisposition) with patients and families before ordering

• Connect families with genetic counselors: National Society of Genetic Counselors at findageneticcounselor.nsgc.org

Treatment Approaches

A genetic diagnosis does not usually change day-to-day psychiatric management—treatment remains symptom-based. The value is in guiding medical monitoring, family counseling, and anticipating long-term vulnerabilities.

• Anxiety or OCD symptoms: SSRIs first line; start low (eg, escitalopram 5 mg, sertraline 25 mg)

• Acute anxiety or agitation: hydroxyzine 25–50 mg as needed

• Irritability or aggression: aripiprazole (start 2 mg) or risperidone (start 0.5–1 mg)—both FDA approved for irritability in autism

• General rule: start low, go slow—these patients are often more sensitive to side effects

Behavioral Strategies (more relevant for inpatient settings)

• Prioritize structure and predictability: consistent routines, visual schedules, minimal unstructured time

• Identify and modify sensory triggers (noise, lighting, crowding); quiet spaces and sensory supports (weighted blankets, fidget tools) can significantly reduce agitation

• Use a functional approach: identify what behavior accomplishes and intervene at that level; reinforce replacement behaviors

• Keep communication simple and concrete; rely heavily on positive reinforcement

• For Prader-Willi: restrict unsupervised food access, use locked storage, schedule structured meals, maintain consistent limit-setting

Clinical Pearls

• Adults with autism or ID may reach adulthood without a genetic diagnosis—especially if early evaluations were limited

• Physical features (mitral valve prolapse, dysmorphic traits), family history patterns, and distinctive behaviors are the key diagnostic clues in adults

• For 22q11.2: think about it whenever you see treatment-resistant psychosis plus a history of childhood cardiac or palate surgery

• Confirming fragile X requires a dedicated test—it will not appear on chromosomal microarray

• A genetic diagnosis can bring families enormous relief after years of uncertainty and reduce guilt or self-blame